<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01105468</url>
  </required_header>
  <id_info>
    <org_study_id>BC1</org_study_id>
    <nct_id>NCT01105468</nct_id>
  </id_info>
  <brief_title>Breath Gas Analysis for the Diagnosis of Breast Cancer</brief_title>
  <official_title>Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ionimed Analytik GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ionimed Analytik GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically
      analyzed by proton-transfer-reaction time of flight mass spectrometry.

      The goal of the study is to determine typical breath gas components that allow to distinguish
      patients with mamma carcinoma from women without carcinoma. Further, the investigators will
      test whether these breath gas markers can be used as tumor markers, which change in a typical
      manner during the progress of the disease. Finally the data will be investigated for the
      presence of marker components, that identify patients who will develop metastasis.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor quit partnership in Oncotyrol-Center for Personalized Medicine, and consequential loss
    of public funding.
  </why_stopped>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breath gas markers</measure>
    <time_frame>3 years</time_frame>
    <description>Breath gas markers that allow to distinguish patients with mamma carcinoma from women without carcinoma;</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">202</enrollment>
  <condition>Mamma Carcinoma</condition>
  <arm_group>
    <arm_group_label>Mamma Carcinoma, no treatment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Mamma Carcinoma, treatment</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>No Mamma Carcinoma diagnosed by X-ray</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Breath Collecting Unit</intervention_name>
    <description>Collect two breath gas samples per patient on one day before surgery</description>
    <arm_group_label>Mamma Carcinoma, no treatment</arm_group_label>
    <arm_group_label>No Mamma Carcinoma diagnosed by X-ray</arm_group_label>
    <other_name>BCU</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Breath Collecting Unit</intervention_name>
    <description>Collect two or more breath gas samples on different days during adjuvant or neo-adjuvant therapy.</description>
    <arm_group_label>Mamma Carcinoma, treatment</arm_group_label>
    <other_name>BCU</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mamma carcinoma diagnosed by histology (cases)

          -  Mamma carcinoma excluded by radiology (controls)

          -  At the time of diagnosis before surgery

          -  At the beginning and during chemotherapy;

        Exclusion Criteria:

          -  No informed consent form singed
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Gynecology and Obstetrics, Medical University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2010</study_first_submitted>
  <study_first_submitted_qc>April 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2010</study_first_posted>
  <last_update_submitted>January 11, 2013</last_update_submitted>
  <last_update_submitted_qc>January 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breath gas analysis</keyword>
  <keyword>Volatile components in exhaled breath</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

